Alexandros Triglimas is a seasoned executive with over two decades of leadership in the pharmaceutical industry, and a proven track record of driving strategic growth and operational excellence across diverse markets, including Europe, CEE, MENA, and Asia. As the CEO of Critica Pharmaceutical PC., he successfully led the company in executing high-impact consulting projects focused on strategic business development, alliances, and portfolio management. His deep expertise in these areas has enabled him to guide the company through complex transformations and achieve sustained success. In his previous role as the Head of Commercial Operations for Elpen Pharmaceutical Group, he was instrumental in managing and expanding the company’s footprint across Europe. He also he served as Elpen’s Group Corporate Development Director and led Group’s strategic partnering and licensing activities in Europe, CEE, MENA, and APAC Markets. He was responsible for signing a large number of contracts in multi-million-euro range for Innovative, Generics and Biosimilars drugs. He holds a BSc in Pharmacy from the Aristotle University of Thessaloniki and an MBA from the Warwick University in UK. He is a certified Pharmacist.